BioLineRx Ltd - Rasio nilai perusahaan marang dodolan BLRX

Simbol resmi perusahaan biolinerx.com (BLRX)

Innovative peptide platforms for stem cell mobilization serve as the foundation for BioLineRx Ltd. (BLRX) growth. This chart in the GURU.Markets terminal illustrates the enterprise value-to-revenue ratio, where 2457.14 determines this specific parameter level. Experts from Israel drive development, while the distribution of Aphexda in the US and strict FDA oversight guarantee commercial success.

BioLineRx Corporation (BLRX): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 19.11.2026

BioLineRx Corp - rincian analitis lan metrik utama (BLRX)

Pambiji fundamental perusahaan:BLRX, biolinerx.com
Produk sing diprodhuksi BioLineRx Ltd

This multiple compares the enterprise value, adjusted for net debt, against generated sales to determine the market revaluation of assets. By analyzing the current enterprise value-to-revenue ratio, an investor can see the scaling efficiency of BioLineRx Ltd. (BLRX), where low production capital expenditures—driven by a royalty-based licensing model—allow the company to maintain a high business valuation even amidst significant R&D expenses.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales